Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Tumor Necrosis Factor Blocker [EPC]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Drug Reports Deaths Death Rate Hosp. Life-Threat. Avg Age % Female
ADALIMUMAB 499,856 21,807 4.4% 108,264 8,132 50.9 yrs 67.6%
ETANERCEPT 358,285 10,338 2.9% 36,932 6,007 54.7 yrs 75.8%
INFLIXIMAB 140,189 7,516 5.4% 36,324 7,479 43.9 yrs 64.4%
CERTOLIZUMAB PEGOL 99,098 5,361 5.4% 17,641 4,574 49.5 yrs 83.1%
GOLIMUMAB 69,222 4,866 7.0% 15,471 4,429 53.0 yrs 79.2%
INFLIXIMAB-DYYB 25,585 632 2.5% 6,251 275 48.5 yrs 54.0%

Head-to-Head Comparisons

ADALIMUMAB vs ETANERCEPT ADALIMUMAB vs INFLIXIMAB ADALIMUMAB vs CERTOLIZUMAB PEGOL ADALIMUMAB vs GOLIMUMAB ETANERCEPT vs INFLIXIMAB ETANERCEPT vs CERTOLIZUMAB PEGOL ETANERCEPT vs GOLIMUMAB INFLIXIMAB vs CERTOLIZUMAB PEGOL INFLIXIMAB vs GOLIMUMAB CERTOLIZUMAB PEGOL vs GOLIMUMAB
← Back to Tumor Necrosis Factor Blocker [EPC] Class side effects →